Fragaki Konstantina, Chaussenot Annabelle, Boutron Audrey, Bannwarth Sylvie, Rouzier Cecile, Chabrol Brigitte, Paquis-Flucklinger Veronique
Université Côte d'Azur, CHU, Inserm, CNRS, IRCAN, France.
Department of Biochemistry, Bicetre Hospital, AP-HP, Paris-Sud Teaching Hospitals, France.
Mol Genet Metab. 2017 Jul;121(3):224-226. doi: 10.1016/j.ymgme.2017.05.002. Epub 2017 May 4.
Patients carrying Acyl-CoA dehydrogenase 9 (ACAD9) mutations reported to date mainly present with severe hypertrophic cardiomyopathy and isolated complex I (CI) dysfunction. Here we report a novel ACAD9 mutation in a young girl presenting with severe hypertrophic cardiomyopathy, isolated CI deficiency and interestingly multiple respiratory chain complexes assembly defects. We show that ACAD9 analysis has to be performed in first intention in patients presenting with cardiac hypertrophy even in the presence of multiple assembly defects.
迄今为止报道的携带酰基辅酶A脱氢酶9(ACAD9)突变的患者主要表现为严重肥厚型心肌病和孤立性复合体I(CI)功能障碍。在此,我们报告了一名年轻女孩中的一种新型ACAD9突变,该女孩表现为严重肥厚型心肌病、孤立性CI缺乏,有趣的是还存在多个呼吸链复合体组装缺陷。我们表明,即使存在多个组装缺陷,对于出现心脏肥大的患者,也必须首先进行ACAD9分析。